1. Home
  2. AIMD vs MTEX Comparison

AIMD vs MTEX Comparison

Compare AIMD & MTEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • MTEX
  • Stock Information
  • Founded
  • AIMD 1984
  • MTEX 1993
  • Country
  • AIMD United States
  • MTEX United States
  • Employees
  • AIMD N/A
  • MTEX N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • MTEX Medicinal Chemicals and Botanical Products
  • Sector
  • AIMD Health Care
  • MTEX Health Care
  • Exchange
  • AIMD Nasdaq
  • MTEX Nasdaq
  • Market Cap
  • AIMD 16.9M
  • MTEX 15.8M
  • IPO Year
  • AIMD N/A
  • MTEX 1999
  • Fundamental
  • Price
  • AIMD $2.27
  • MTEX $9.51
  • Analyst Decision
  • AIMD
  • MTEX
  • Analyst Count
  • AIMD 0
  • MTEX 0
  • Target Price
  • AIMD N/A
  • MTEX N/A
  • AVG Volume (30 Days)
  • AIMD 37.4K
  • MTEX 28.3K
  • Earning Date
  • AIMD 11-13-2025
  • MTEX 11-12-2025
  • Dividend Yield
  • AIMD N/A
  • MTEX N/A
  • EPS Growth
  • AIMD N/A
  • MTEX N/A
  • EPS
  • AIMD N/A
  • MTEX N/A
  • Revenue
  • AIMD $113,037.00
  • MTEX $112,975,000.00
  • Revenue This Year
  • AIMD N/A
  • MTEX N/A
  • Revenue Next Year
  • AIMD N/A
  • MTEX N/A
  • P/E Ratio
  • AIMD N/A
  • MTEX N/A
  • Revenue Growth
  • AIMD 178.19
  • MTEX N/A
  • 52 Week Low
  • AIMD $2.00
  • MTEX $7.50
  • 52 Week High
  • AIMD $5.00
  • MTEX $16.49
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 28.33
  • MTEX 53.93
  • Support Level
  • AIMD $2.59
  • MTEX $9.20
  • Resistance Level
  • AIMD $3.16
  • MTEX $9.89
  • Average True Range (ATR)
  • AIMD 0.24
  • MTEX 0.71
  • MACD
  • AIMD -0.11
  • MTEX 0.03
  • Stochastic Oscillator
  • AIMD 0.00
  • MTEX 23.27

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

Share on Social Networks: